Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 851-875 of 2,022
CompletedNCT04578756

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolarity I, or Autism Spectrum Disorder

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 5 Years to 17 Years
Countries
United States
Sponsor
AbbVie
Condition
Schizophrenia
SuspendedNCT03513549

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolarity I

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Alexza Pharmaceuticals, Inc.
Condition
Schizophrenia
TerminatedNCT00288353

Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
CompletedNCT04118283

Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
CompletedNCT03740139

The Police-Mental Health Linkage System

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
Columbia University
Condition
Depression
CompletedNCT07140042

Physical Fitness, Physical Activity Level, Depression and Quality of Life in Bipolar and Schizophrenia Patients

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Condition
Depression
CompletedNCT03481049

Individualizing Incentives for Alcohol in the Severely Mentally Ill

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Washington State University
Condition
Depression
CompletedNCT04436757

Self and Body-esteem in Socio-professional Rehabilitation

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

DepressionOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Depression
CompletedNCT02360267

Pediatric Bipolar Registry

This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

BipolarityOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity
CompletedNCT04870710

Feasibility Electrical Stimulation Study for Visual Hallucinations

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Schizophrenia
WithdrawnNCT06328140

Sleep Quality, Cognitive Performance, and Computerized Cognitive Training

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
George West Mental Health Foundation d/b/a Skyland Trail
Condition
Depression
CompletedNCT03943537

Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia
CompletedNCT00178932

Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors

This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
CompletedNCT04004416

Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis

This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 16 Years to 60 Years
Countries
United States
Sponsor
University of Michigan
Condition
Schizophrenia
CompletedNCT06486584

Contingency Management for Problematic Behavior Reduction in the Community

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Laureate Institute for Brain Research, Inc.
Condition
Schizophrenia
CompletedNCT03079024

Minnesota Community-Based Cognitive Training in Early Psychosis

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
CompletedNCT02815813

Lifestyle Intervention for Young Adults With Serious Mental Illness

This study exists to see whether a guided support group can make care clearer and more responsive. Researchers are trying to understand whether a guided support group can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia
CompletedNCT00512070

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

This study exists to see whether blood tests and biological markers is workable and worth testing more broadly. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Seattle Institute for Biomedical and Clinical Research
Condition
Schizophrenia